- Home
- STOK vs MEGI Comparison
STOK vs MEGI Comparison
Compare STOK & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- MEGI
- Stock Information
- Founded
- STOK 2014
- MEGI 2021
- Country
- STOK United States
- MEGI United States
- Employees
- STOK N/A
- MEGI N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- MEGI Investment Managers
- Sector
- STOK Health Care
- MEGI Finance
- Exchange
- STOK Nasdaq
- MEGI Nasdaq
- Market Cap
- STOK 556.7M
- MEGI 647.0M
- IPO Year
- STOK 2019
- MEGI N/A
- Fundamental
- Price
- STOK $8.33
- MEGI $12.65
- Analyst Decision
- STOK Strong Buy
- MEGI
- Analyst Count
- STOK 8
- MEGI 0
- Target Price
- STOK $23.83
- MEGI N/A
- AVG Volume (30 Days)
- STOK 830.1K
- MEGI 178.0K
- Earning Date
- STOK 03-24-2025
- MEGI 01-01-0001
- Dividend Yield
- STOK N/A
- MEGI 11.40%
- EPS Growth
- STOK N/A
- MEGI N/A
- EPS
- STOK N/A
- MEGI N/A
- Revenue
- STOK $16,742,999.00
- MEGI N/A
- Revenue This Year
- STOK $105.42
- MEGI N/A
- Revenue Next Year
- STOK $15.13
- MEGI N/A
- P/E Ratio
- STOK N/A
- MEGI N/A
- Revenue Growth
- STOK 81.08
- MEGI N/A
- 52 Week Low
- STOK $5.28
- MEGI $10.63
- 52 Week High
- STOK $17.58
- MEGI $14.89
- Technical
- Relative Strength Index (RSI)
- STOK 32.00
- MEGI 54.45
- Support Level
- STOK $9.76
- MEGI $12.50
- Resistance Level
- STOK $11.11
- MEGI $12.67
- Average True Range (ATR)
- STOK 0.88
- MEGI 0.16
- MACD
- STOK -0.30
- MEGI 0.03
- Stochastic Oscillator
- STOK 2.31
- MEGI 91.75
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
MainStay CBRE Global Infrastructure Megatrends Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It invests predominantly in income-producing equity securities issued by infrastructure companies, including common stock, preferred stock, convertible securities, and rights or warrants to buy common stocks. The company intends to focus on three infrastructure megatrends: decarbonization, digital transformation, and asset modernization while making its investments.